BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/30/2024 9:49:59 AM | Browse: 44 | Download: 106
 |
Received |
|
2024-10-12 14:53 |
|
Peer-Review Started |
|
2024-10-12 14:53 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2024-10-30 02:21 |
|
Revised |
|
2024-11-09 21:36 |
|
Second Decision |
|
2024-12-11 02:43 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2024-12-11 10:08 |
|
Articles in Press |
|
2024-12-11 10:08 |
|
Publication Fee Transferred |
|
2024-11-12 04:39 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2024-12-23 07:11 |
|
Publish the Manuscript Online |
|
2024-12-30 09:49 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Zhi-Yuan Yao, Xiao Ma, Yong-Zheng Cui, Jie Liu, Zheng-Xiang Han and Jun Song |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jun Song, PhD, Professor, Department of Gastrointestinal Surgery, The Affiliated Hospital of Xuzhou Medical College, No. 99 Huaihai West Road, Quanshan District, Xuzhou 221000, Jiangsu Province, China. 1447795006@qq.com |
| Key Words |
Triglyceride glucose index; Gastric cancer; Sintilimab; Prognostic model; Efficacy; Safety |
| Core Tip |
Gastric cancer (GC) is the fifth most common malignancy. Despite advancements in immunotherapies, patient prognosis remains poor, necessitating the identification of key prognostic factors to optimize treatment approaches. Triglyceride glucose (TyG) index is increasingly recognized for its impact on cancer progression and immune modulation, and its potential role in GC prognosis is of particular interest. However, only a few studies have explored the effect of the TyG index on the prognosis of patients with advanced GC. Therefore, we initiated a retrospective clinical study to explore the impact of the TyG index on the prognosis of patients with advanced GC receiving immunosuppressive agents when combined with chemotherapy. |
| Publish Date |
2024-12-30 09:49 |
| Citation |
<p>Yao ZY, Ma X, Cui YZ, Liu J, Han ZX, Song J. Impact of triglyceride-glucose index on the long-term prognosis of advanced gastric cancer patients receiving immunotherapy combined with chemotherapy. <i>World J Gastroenterol</i> 2025; 31(5): 102249</p> |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i5/102249.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i5.102249 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
